牛叉诊股

[{"date":"2026.04.16","stock":"-0.74","trade":"-0.13","ind":"0.70"},{"date":"2026.04.15","stock":"0.95","trade":"2.03","ind":"0.01"},{"date":"2026.04.14","stock":"-0.97","trade":"0.36","ind":"0.95"},{"date":"2026.04.13","stock":"-1.19","trade":"-1.82","ind":"0.06"},{"date":"2026.04.10","stock":"1.54","trade":"0.01","ind":"0.51"},{"date":"2026.04.09","stock":"-2.34","trade":"-1.54","ind":"-0.72"},{"date":"2026.04.08","stock":"0.70","trade":"0.62","ind":"2.70"},{"date":"2026.04.07","stock":"-2.24","trade":"0.87","ind":"0.26"},{"date":"2026.04.03","stock":"0.23","trade":"-2.39","ind":"-1.00"},{"date":"2026.04.02","stock":"2.36","trade":"0.62","ind":"-0.74"},{"date":"2026.04.01","stock":"2.05","trade":"2.36","ind":"1.46"},{"date":"2026.03.31","stock":"-1.52","trade":"-0.69","ind":"-0.80"},{"date":"2026.03.30","stock":"2.52","trade":"1.18","ind":"0.24"},{"date":"2026.03.27","stock":"2.09","trade":"2.53","ind":"0.63"},{"date":"2026.03.26","stock":"0.31","trade":"-0.80","ind":"-1.09"},{"date":"2026.03.25","stock":"0.56","trade":"1.38","ind":"1.30"},{"date":"2026.03.24","stock":"-1.64","trade":"3.44","ind":"1.78"},{"date":"2026.03.23","stock":"5.25","trade":"-5.85","ind":"-3.63"},{"date":"2026.03.20","stock":"-0.38","trade":"-1.99","ind":"-1.24"},{"date":"2026.03.19","stock":"-1.63","trade":"-1.92","ind":"-1.39"},{"date":"2026.03.18","stock":"-0.03","trade":"0.39","ind":"0.32"}]

健民集团,上证指数,中药指数

压力支撑

该股压力位为33.60元，支撑位为33.17元。

[{"text":"\u538b\u529b\u4f4d","value":"33.60","date":1776268800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"33.17","date":1776268800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.0资金面打败了21%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月16日 20:31

机构今日流向(万元)	-959.75	机构5日流向(万元)	-3498.80
机构10日流向(万元)	-7768.34	机构20日流向(万元)	-9358.07

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少515.48万股，其中基金净减仓3家，主力净减仓56家，请投资者中长期谨慎为宜。

截止2025-12-31，共54家主力机构（基金48家，一般法人5家，券商1家），持仓量总计5873.64万股，占流通A股38.32%
其中，基金持仓与2025-06-30相比：
增仓：9家，增持 107.40万股
减仓：12家，减持 233.24万股
新出现在主力名单中：14家，持有362.06万股
从主力名单中消失：70家，原持有699.47万股

消息面诊股

诊断结果：6.6消息面打败了84%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-03-21
利好	分红转增	10派9元(含税)	2026-03-21
一般消息	分红转增	不分配不转增	2025-08-20
一般消息	高管变动	取消监事会	2025-07-30
一般消息	高管变动	因工作调整	2025-05-09

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：5.8行业面打败了70%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.16","price":"0.70","value":"-0.13"},{"date":"2026.04.15","price":"0.01","value":"2.03"},{"date":"2026.04.14","price":"0.95","value":"0.36"},{"date":"2026.04.13","price":"0.06","value":"-1.82"},{"date":"2026.04.10","price":"0.51","value":"0.01"},{"date":"2026.04.09","price":"-0.72","value":"-1.54"},{"date":"2026.04.08","price":"2.70","value":"0.62"},{"date":"2026.04.07","price":"0.26","value":"0.87"},{"date":"2026.04.03","price":"-1.00","value":"-2.39"},{"date":"2026.04.02","price":"-0.74","value":"0.62"},{"date":"2026.04.01","price":"1.46","value":"2.36"},{"date":"2026.03.31","price":"-0.80","value":"-0.69"},{"date":"2026.03.30","price":"0.24","value":"1.18"},{"date":"2026.03.27","price":"0.63","value":"2.53"},{"date":"2026.03.26","price":"-1.09","value":"-0.80"},{"date":"2026.03.25","price":"1.30","value":"1.38"},{"date":"2026.03.24","price":"1.78","value":"3.44"},{"date":"2026.03.23","price":"-3.63","value":"-5.85"},{"date":"2026.03.20","price":"-1.24","value":"-1.99"},{"date":"2026.03.19","price":"-1.39","value":"-1.92"},{"date":"2026.03.18","price":"0.32","value":"0.39"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	63.53%	-10.07%	5.3分
2	沃华医药	19.62%	6.01%	6.2分
3	益佰制药	17.59%	-7.51%	4.4分
4	康恩贝	11.76%	12.02%	6.4分
5	康惠股份	8.89%	14.35%	5.9分
6	华润江中	5.98%	2.83%	6.6分
7	九芝堂	5.87%	2.10%	5.7分
8	健民集团	5.68%	-0.44%	5.6分
9	ST香雪	4.94%	-9.37%	4.8分
10	东阿阿胶	4.86%	0.83%	6.1分
11	振东制药	4.65%	2.61%	4.9分
12	众生药业	3.01%	1.29%	5.3分
13	ST葫芦娃	2.66%	1.17%	4.6分
14	华森制药	2.54%	2.33%	5.5分
15	广誉远	2.24%	1.11%	5.4分
16	亚宝药业	1.96%	3.20%	6.3分
17	桂林三金	1.84%	1.41%	5.8分
18	红日药业	1.68%	2.25%	5.5分
19	以岭药业	1.30%	3.87%	5.9分
20	天士力	1.19%	1.98%	5.7分
21	精华制药	0.52%	0.00%	5.9分
22	仁和药业	0.00%	0.51%	5.2分
23	步长制药	-0.18%	2.06%	5.9分
24	华神科技	-0.48%	2.21%	5.9分
25	中恒集团	-0.77%	0.39%	5.1分
26	太极集团	-0.90%	0.55%	5.2分
27	吉林敖东	-1.02%	3.49%	5.3分
28	信邦制药	-1.19%	1.85%	5.3分
29	太龙药业	-1.22%	1.96%	4.8分
30	陇神戎发	-1.34%	1.05%	5.8分
31	ST百灵	-1.38%	-0.20%	4.6分
32	葵花药业	-1.67%	1.31%	4.1分
33	康缘药业	-1.82%	1.74%	5.1分
34	汉森制药	-1.87%	2.25%	5.7分
35	千金药业	-2.08%	0.46%	6.3分
36	粤万年青	-2.22%	-6.63%	4.5分
37	云南白药	-2.36%	0.76%	6.4分
38	特一药业	-2.40%	-1.08%	5.8分
39	奇正藏药	-2.46%	1.47%	5.6分
40	佐力药业	-2.69%	1.60%	5.4分
41	佛慈制药	-3.35%	-0.80%	5.4分
42	马应龙	-3.43%	-1.30%	5.0分
43	嘉应制药	-3.62%	-2.03%	5.1分
44	恩威医药	-3.85%	2.41%	6.2分
45	三力制药	-3.97%	0.91%	5.7分
46	羚锐制药	-4.24%	-3.01%	5.0分
47	金花股份	-4.38%	-4.27%	4.5分
48	上海凯宝	-4.60%	0.67%	5.3分
49	达仁堂	-4.77%	0.22%	5.5分
50	-	-5.06%	1.25%	分
51	华润三九	-5.12%	0.40%	5.8分
52	益盛药业	-5.13%	1.27%	5.5分
53	盘龙药业	-5.40%	-1.52%	4.5分
54	寿仙谷	-5.59%	-0.11%	5.2分
55	新天药业	-5.63%	-8.43%	5.0分
56	新光药业	-5.87%	1.12%	5.2分
57	康美药业	-5.88%	0.00%	5.1分
58	-	-5.98%	1.76%	分
59	维康药业	-6.26%	-1.78%	4.7分
60	昆药集团	-6.39%	-0.27%	4.7分
61	片仔癀	-6.46%	-1.87%	4.5分
62	珍宝岛	-6.81%	4.11%	4.6分
63	古汉医药	-6.83%	1.67%	5.8分
64	同仁堂	-7.05%	1.12%	5.3分
65	济川药业	-8.15%	-1.64%	5.2分
66	天目药业	-8.23%	-9.26%	5.0分
67	方盛制药	-9.67%	-0.74%	5.3分
68	白云山	-9.83%	0.31%	5.7分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.9基本面打败了89%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/107 ， 27/107。

[{"date":"2025-09-30","value":"11.39","vol":"4.81"},{"date":"2025-06-30","value":"8.91","vol":"4.04"},{"date":"2025-03-31","value":"4.42","vol":"2.25"},{"date":"2024-12-31","value":"15.47","vol":"4.87"},{"date":"2024-09-30","value":"13.86","vol":"5.62"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	11.39	8.91	4.42	15.47	13.86
行业(%)	4.81	4.04	2.25	4.87	5.62

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"59.20","vol":"53.26"},{"date":"2025-06-30","value":"59.44","vol":"53.79"},{"date":"2025-03-31","value":"57.61","vol":"54.43"},{"date":"2024-12-31","value":"47.73","vol":"53.69"},{"date":"2024-09-30","value":"43.00","vol":"53.56"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	59.20	59.44	57.61	47.73	43.00
行业(%)	53.26	53.79	54.43	53.69	53.56

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 41/107 ， 39/107。

[{"date":"2025-09-30","value":"-11.43","vol":"-7.81"},{"date":"2025-06-30","value":"-10.20","vol":"-7.74"},{"date":"2025-03-31","value":"-8.04","vol":"-7.31"},{"date":"2024-12-31","value":"-16.81","vol":"-6.13"},{"date":"2024-09-30","value":"-7.58","vol":"-3.58"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-11.43	-10.20	-8.04	-16.81	-7.58
行业(%)	-7.81	-7.74	-7.31	-6.13	-3.58

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-11.16","vol":"-2.50"},{"date":"2025-06-30","value":"-7.83","vol":"2.58"},{"date":"2025-03-31","value":"10.70","vol":"-37.35"},{"date":"2024-12-31","value":"-30.55","vol":"-148.45"},{"date":"2024-09-30","value":"-22.53","vol":"65.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-11.16	-7.83	10.70	-30.55	-22.53
行业(%)	-2.50	2.58	-37.35	-148.45	65.47

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/107 ， 7/107。

[{"date":"2025-09-30","value":"0.59","vol":"0.35"},{"date":"2025-06-30","value":"0.42","vol":"0.24"},{"date":"2025-03-31","value":"0.21","vol":"0.13"},{"date":"2024-12-31","value":"0.83","vol":"0.50"},{"date":"2024-09-30","value":"0.69","vol":"0.38"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.59	0.42	0.21	0.83	0.69
行业(次)	0.35	0.24	0.13	0.50	0.38

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"3.14","vol":"1.72"},{"date":"2025-06-30","value":"2.25","vol":"1.17"},{"date":"2025-03-31","value":"1.15","vol":"0.60"},{"date":"2024-12-31","value":"4.55","vol":"2.41"},{"date":"2024-09-30","value":"4.23","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	3.14	2.25	1.15	4.55	4.23
行业(次)	1.72	1.17	0.60	2.41	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"11.15","vol":"10.53"},{"date":"2025-06-30","value":"8.83","vol":"22.82"},{"date":"2025-03-31","value":"-2.79","vol":"2.07"},{"date":"2024-12-31","value":"20.60","vol":"22.07"},{"date":"2024-09-30","value":"5.80","vol":"6.09"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	11.15	8.83	-2.79	20.60	5.80
行业	10.53	22.82	2.07	22.07	6.09

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.26","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.70","vol":"1.48"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.26	-	1.70	-
行业	0.00	1.03	0.00	1.48	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 19/107 ， 19/107。

[{"date":"2025-09-30","value":"1.59","vol":"3.09"},{"date":"2025-06-30","value":"1.56","vol":"2.94"},{"date":"2025-03-31","value":"1.65","vol":"3.03"},{"date":"2024-12-31","value":"1.49","vol":"2.92"},{"date":"2024-09-30","value":"1.57","vol":"3.30"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.59	1.56	1.65	1.49	1.57
行业	3.09	2.94	3.03	2.92	3.30

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.34","vol":"2.24"},{"date":"2025-06-30","value":"1.33","vol":"2.15"},{"date":"2025-03-31","value":"1.39","vol":"2.24"},{"date":"2024-12-31","value":"1.20","vol":"2.13"},{"date":"2024-09-30","value":"1.30","vol":"2.46"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.34	1.33	1.39	1.20	1.30
行业	2.24	2.15	2.24	2.13	2.46

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 12/107 ， 19/107。

[{"date":"2025-09-30","value":"40.05","vol":"31.59"},{"date":"2025-06-30","value":"41.44","vol":"32.44"},{"date":"2025-03-31","value":"40.15","vol":"31.90"},{"date":"2024-12-31","value":"42.72","vol":"32.73"},{"date":"2024-09-30","value":"42.78","vol":"32.27"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	40.05	41.44	40.15	42.72	42.78
行业(%)	31.59	32.44	31.90	32.73	32.27

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.67","vol":"0.76"},{"date":"2025-06-30","value":"0.71","vol":"0.75"},{"date":"2025-03-31","value":"0.67","vol":"0.74"},{"date":"2024-12-31","value":"0.75","vol":"0.76"},{"date":"2024-09-30","value":"0.75","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.67	0.71	0.67	0.75	0.75
行业(%)	0.76	0.75	0.74	0.76	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
国海证券	2026-03-26	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"4.08","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.21","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.62","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.60","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"4.61","blueLineValue":"3.00","type":"YC"}]

[健民集团]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]